Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 8/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.37 |
| ▸ | PPARG | P37231 | 6/20 | 0.37 |
| ▸ | PPARD | Q03181 | 6/20 | 0.37 |
| ▸ | PPARA | Q07869 | 6/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL30937464 | 0.86 | AKR1B1 (0.59) | ALDH1A1TSHRAKR1B1GPR84PPARG | |
| Stearic Acid SCHEMBL27788362 | 0.85 | GPR84 (0.61) | ALDH1A1TSHRAKR1B1GPR84PPARG | |
| Dodecanoate SCHEMBL27781821 | 0.85 | GPR84 (0.61) | ALDH1A1TSHRAKR1B1GPR84PPARG | |
| Propionic Acid SCHEMBL27991669 | 0.85 | ALDH1A1 (0.71) | ALDH1A1FFAR3TSHRTHRBEGLN1 | |
| Butane SCHEMBL7941631 | 0.84 | ALDH1A1 (0.79) | ALDH1A1TSHRTHRBEGLN1TDP1 | |
| SCHEMBL8068615 | 0.84 | ALDH1A1 (0.58) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL28857277 | 0.83 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBMEN1KMT2A | |
| SCHEMBL11706141 | 0.83 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Methacrylic Acid SCHEMBL29227342 | 0.82 | ALDH1A1 (0.56) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Propane SCHEMBL23527365 | 0.82 | ALDH1A1 (0.83) | ALDH1A1TSHRTHRBEGLN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| US-10350093-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORPORATION (US) | 2019-07-16 | — | — | US | claimed |
| EP-3225216-A1 | DEGRADABLE IMPLANTABLE MEDICAL DEVICES | Elixir Medical Corporation (US) | 2017-10-04 | — | — | EP | claimed |
| EP-2796112-B1 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2016-11-16 | — | — | EP | claimed |
| EP-2796112-A1 | Degradable implantable medical devices | Elixir Medical Corporation (US) | 2014-10-29 | — | — | EP | claimed |
| EP-1355588-B1 | Device for delivery of therepeutic agents | AVANTEC VASCULAR CORP (US) | 2007-08-15 | — | — | EP | claimed |
| US-20060106453-A1 | Delivery of therapeutic capable agents | AVANTEC VASCULAR CORPORATION (US) | 2006-05-18 | — | — | US | claimed |
| WO-2005051229-A2 | DEVICES DELIVERING THERAPEUTIC AGENTS AND METHODS REGARDING THE SAME | AVANTEC VASCULAR CORPORATION (US) | 2005-06-09 | — | — | WO | claimed |
| US-20050125054-A1 | Devices delivering therapeutic agents and methods regarding the same | AVANTEC VASCULAR CORPORATION (US) | 2005-06-09 | — | — | US | claimed |
| JP-2004523275-A | — | — | 2004-08-05 | — | — | JP | claimed |
| EP-1355588-A4 | DELIVERY OF THERAPEUTIC CAPABLE AGENTS | AVANTEC VASCULAR CORP (US) | 2004-03-31 | — | — | EP | claimed |
| EP-1355588-A2 | DELIVERY OF THERAPEUTIC CAPABLE AGENTS | Avantec Vascular Corporation (US) | 2003-10-29 | — | — | EP | claimed |
| WO-2002056790-A2 | DELIVERY OF THERAPEUTIC CAPABLE AGENTS | AVANTEC VASCULAR CORPORATION (US) | 2002-07-25 | — | — | WO | claimed |
| US-20020082679-A1 | Delivery or therapeutic capable agents | AVANTEC VASCULAR CORPORATION | 2002-06-27 | — | — | US | claimed |
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | disclosed |
| US-20200188142-A1 | DEGRADABLE IMPLANTABLE MEDICAL DEVICES | ELIXIR MEDICAL CORPORATION (US) | 2020-06-18 | — | — | US | disclosed |
| US-10350093-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORPORATION (US) | 2019-07-16 | — | — | US | disclosed |
| US-20020082679-A1 | Delivery or therapeutic capable agents | AVANTEC VASCULAR CORPORATION | 2002-06-27 | — | — | US | disclosed |
| US-4251576-A | LOW VISCOSITY | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-02-17 | — | — | US | disclosed |
| US-4221697-A | Composite materials | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-09-09 | — | — | US | disclosed |